Skip to content

Effects of dietary sodium restriction and mineralocorticoid receptor antagonist in patients with Chronic kidney disease stages 1~3: a randomized controlled trial

Effects of dietary sodium restriction and mineralocorticoid receptor antagonist in patients with Chronic kidney disease stages 1~3: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026991
Enrollment
Unknown
Registered
2019-10-28
Start date
2014-09-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

A:low sodium, salt 3g/d+SPL simulator
B:medium sodium, salt 5g/d +SPL
C:low sodium, salt 3g/d+SPL

Sponsors

Hangzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. primary chronic glomerular disease, and accompanied by urinary protein or urinary albumin positive; 2. estimation of glomerular filtration rate (eGFR) >= 30ml/min/1.73m2; 3. aged 18-70 years, gender is not limited; 4. no clinical evidence of acute injury; 5. No mental abnormalities, able to cooperate.

Exclusion criteria

Exclusion criteria: 1. patients who have received glucocorticoid or immunosuppressant or non-steroidal anti-inflammatory drug (NSAID) treatment for more than one week in the last 3 months; 2. heart, brain, lung, liver or hematopoietic system and other serious primary diseases; 3. have malignant tumors, tuberculosis and other acute infectious diseases; 4. pregnancy, breast-feeding, or recently prepared to conceive; 5. patients allergic to glucocorticoid receptor antagonist (MRA), such as spironolactone (SPL); 6. patients who are participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
24-hour proteinuria;

Secondary

MeasureTime frame
blood pressure;eGFR;

Countries

China

Contacts

Public ContactZhang Hongmei

Hangzhou Hospital of Traditional Chinese Medicine

lh85281908@sina.com+86 13906506858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026